A large contemporary U.S. electronic health record analysis highlights elevated risks of severe maternal morbidity and preterm birth among pregnant individuals with sickle cell disease, offering updated...
A large contemporary U.S. electronic health record analysis highlights elevated risks of severe maternal morbidity and preterm birth among pregnant individuals with sickle cell disease, offering updated...
A new multicenter UK audit evaluated dapagliflozin use in adults with sickle cell disease–associated chronic kidney disease, offering clinicians early insight into safety, tolerability, and renal effects in...
A new multicenter UK audit evaluated dapagliflozin use in adults with sickle cell disease–associated chronic kidney disease, offering clinicians early insight into safety, tolerability, and renal effects in...
A new multicenter UK audit evaluated dapagliflozin use in adults with sickle cell disease–associated chronic kidney disease, offering clinicians early insight into safety, tolerability, and renal effects in...
A new multicenter UK audit evaluated dapagliflozin use in adults with sickle cell disease–associated chronic kidney disease, offering clinicians early insight into safety, tolerability, and renal effects in...
Treatment with lumasiran improved kidney outcomes in patients with primary hyperoxaluria type 1, with no cases of end-stage kidney disease observed during follow-up in a study presented at Kidney Week....
Treatment with lumasiran improved kidney outcomes in patients with primary hyperoxaluria type 1, with no cases of end-stage kidney disease observed during follow-up in a study presented at Kidney Week....
Treatment with lumasiran improved kidney outcomes in patients with primary hyperoxaluria type 1, with no cases of end-stage kidney disease observed during follow-up in a study presented at Kidney Week....
Treatment with lumasiran improved kidney outcomes in patients with primary hyperoxaluria type 1, with no cases of end-stage kidney disease observed during follow-up in a study presented at Kidney Week....
